Vincent Rajkumar: My view on what the word Cure should mean in myeloma
Vincent Rajkumar shared a post on X:
“At COMy Congress I laid out my view on what the word Cure should mean in myeloma (and in cancer).
Thanks Mohamad Mohty for taking the video.
It’s easy to redefine cure and make it easier to attain. But we shouldn’t. More here.
I’m pleased that there are multiple randomized trials which have finite duration of therapy in the newly diagnosed setting.
I’m also pleased with the fact that we have launched trials with curative intent.
More on how we define cure. We know we are curing a disease when you see curves like you do with DLBCL and Hodgkins.”
Proceed to video attached to the post.
Source: Vincent Rajkumar/X
Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group. He also chairs the Board of directors of The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee. His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023